Evidence map›Paper›PMID 29494697›Full record

ArticlePloS one2018

Sickle cell maculopathy: Identification of systemic risk factors, and microstructural analysis of individual retinal layers of the macula.

Laura Dell'Arti, Giulio Barteselli, Lorenzo Riva, Elisa Carini, Giovanna Graziadei, Eleonora Benatti, Alessandro Invernizzi, Maria D Cappellini, Francesco Viola

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 42 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Preferential Sites of Retinal Capillary Occlusion in Sickle Cell Disease.Investigative ophthalmology & visual science · 2025
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Optical coherence tomography (OCT) and OCT angiography allow early identification of sickle cell maculopathy in children and correlate it with systemic risk factors.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2020
    Article
  14. Review
  15. Hemoglobin level and macular thinning in sickle cell disease.Clinical ophthalmology (Auckland, N.Z.) · 2019
    Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Laura Dell'ArtiDepartment of Clinical Sciences and Community Health, University of Milan, Milan, Italy.
Giulio BarteselliGenentech Inc, South San Francisco, California, United States of America.
Lorenzo RivaOphthalmological Unit, Ca' Granda Foundation, IRCCS Ospedale Maggiore Policlinico, Milan, Italy.
Elisa CariniOphthalmological Unit, Ca' Granda Foundation, IRCCS Ospedale Maggiore Policlinico, Milan, Italy.
Giovanna GraziadeiRare Diseases Center, Department of Medicine and Medical Specialties, Ca' Granda Foundation, IRCCS Ospedale Maggiore Policlinico, Milan, Italy.
Eleonora BenattiOphthalmological Unit, Ca' Granda Foundation, IRCCS Ospedale Maggiore Policlinico, Milan, Italy.
Alessandro InvernizziEye Clinic, Department of Biomedical and Clinical Science "L. Sacco", Luigi Sacco Hospital, University of Milan, Milan, Italy.
Maria D CappelliniDepartment of Clinical Sciences and Community Health, University of Milan, Milan, Italy.
Francesco ViolaDepartment of Clinical Sciences and Community Health, University of Milan, Milan, Italy.ORCID 0000-0003-0533-1135
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico · ITUniversity of Milan · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo identify systemic risk factors for sickle cell maculopathy, and to analyze the microstructure of the macula of Sickle Cell Disease (SCD) patients by using automated segmentation of individual retinal layers.

methodsThirty consecutive patients with SCD and 30 matched controls underwent spectral-domain optical coherence tomography (SD-OCT) and automated thickness measurement for each retinal layer; thicknesses for SCD patients were then compared to normal controls. Demographic data, systemic data, and lab results were collected for each SCD patient; multivariate logistic regression analysis was used to identify potential risk factors for sickle cell maculopathy.

resultsOngoing chelation treatment (p = 0.0187) was the most predictive factor for the presence of sickle cell maculopathy; the odds were 94.2% lower when chelation was present. HbF level tended to influence sickle cell maculopathy (p = 0.0775); the odds decreased by 12.9% when HbF increased by 1%. Sickle cell maculopathy was detected in 43% of SCD patients as patchy areas of retinal thinning on SD-OCT thickness map, mostly located temporally to the macula, especially in eyes with more advanced forms of sickle cell retinopathy (p = 0.003). In comparison to controls, SCD patients had a subtle thinning of the overall macula and temporal retina compared to controls (most p<0.0001), involving inner and outer retinal layers. Thickening of the retinal pigment epithelium was also detected in SCD eyes (p<0.0001).

conclusionsChronic chelation therapy and, potentially, high levels of HbF are possible protective factors for the presence of sickle cell maculopathy, especially for patients with more advanced forms of sickle cell retinopathy. A subtle thinning of the overall macula occurs in SCD patients and involves multiple retinal layers, suggesting that ischemic vasculopathy may happen in both superficial and deep capillary plexi. Thinning of the outer retinal layers suggests that an ischemic insult of the choriocapillaris may also occur in SCD patients.

Indexed as

AdultAgedAnemia, Sickle CellChelation TherapyFemaleFetal HemoglobinFluorescein AngiographyHumansMacula LuteaMaleMiddle AgedOdds RatioRetinal DiseasesRisk FactorsTomography, Optical CoherenceYoung AdultFetal Hemoglobin

Identifiers

PMID29494697
PMCPMC5832302
OpenAlexW2793352746

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.